• Publications
  • Influence
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this first of 5 sections of theExpand
  • 1,079
  • 55
  • PDF
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.
Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this fourth of 6 sections of theExpand
  • 480
  • 32
  • PDF
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and
Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In the first 5 parts of the AmericanExpand
  • 484
  • 23
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this second of 5 sections of theExpand
  • 724
  • 18
  • PDF
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy.
Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this fifth of 6 sections of theExpand
  • 295
  • 12
  • PDF
Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.
  • J. Koo
  • Medicine
  • Dermatologic clinics
  • 1 July 1996
With the changing health care scene in the United States, it is important to have up-to-date epidemiological data with regard to the prevalence of psoriasis in the United States. It is also becomingExpand
  • 372
  • 11
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.
Psoriasis is a common, chronic, inflammatory, multi-system disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this third of 6 sections of theExpand
  • 428
  • 11
  • PDF
Improved health‐related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis
Background  Psoriasis has a negative impact on patients' quality of life. Treatment strategies should address both the cutaneous manifestations of the disease and their impact on quality of life.
  • 94
  • 8
The psychosocial impact of acne: patients' perceptions.
  • J. Koo
  • Medicine
  • Journal of the American Academy of Dermatology
  • 1 May 1995
There is no single disease which causes more psychic trauma, more maladjustment between parent and children, more general insecurity and feelings of inferiority and greater sums of psychic sufferingExpand
  • 196
  • 7
Quality of life issues in psoriasis.
  • J. Choi, J. Koo
  • Medicine
  • Journal of the American Academy of Dermatology
  • 1 August 2003
Psoriasis is associated with significant psychosocial morbidity and a decrease in health-related quality of life. It is important to view psoriasis as a serious disease and resist the tendency toExpand
  • 227
  • 7